Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sanchez-Carbayo

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Medicinal Chemistry|December 6, 2013
The neuroendocrine component in bladder tumorsN Pompas-Veganzones, P Gonzalez-Peramato, M Sanchez-Carbayo
Anticancer Research|January 12, 2000
Autoantibodies against P53 protein in patients with transitional cell carcinoma of the bladderM Sanchez-Carbayo, M T Chulia, M Niveiro, et al.
Anticancer Research|November 20, 2001
Serial urinary IL-2, IL-6, IL-8, TNFalpha, UBC, CYFRA 21-1 and NMP22 during follow-up of patients with bladder cancer receiving intravesical BCGM Sanchez-Carbayo, M Urrutia, R Romani, et al.
British Journal of Cancer|December 19, 2007
Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarraysA Aleman, L Adrien, L Lopez-Serra, et al.
British Journal of Cancer|April 4, 2013
Putative tumour suppressor gene necdin is hypermethylated and mutated in human cancerL E De Faveri, C D Hurst, F M Platt, et al.
Journal of Biological Regulators and Homeostatic Agents|July 9, 2013
Fluorescence in situ hybridization analysis of CCND3 gene as marker of progression in bladder carcinomaA L Beltran, J L Ordonez, A P Otero, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Medicinal Chemistry|December 6, 2013
The neuroendocrine component in bladder tumorsN Pompas-Veganzones, P Gonzalez-Peramato, M Sanchez-Carbayo
Anticancer Research|January 12, 2000
Autoantibodies against P53 protein in patients with transitional cell carcinoma of the bladderM Sanchez-Carbayo, M T Chulia, M Niveiro, et al.
Anticancer Research|November 20, 2001
Serial urinary IL-2, IL-6, IL-8, TNFalpha, UBC, CYFRA 21-1 and NMP22 during follow-up of patients with bladder cancer receiving intravesical BCGM Sanchez-Carbayo, M Urrutia, R Romani, et al.
British Journal of Cancer|December 19, 2007
Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarraysA Aleman, L Adrien, L Lopez-Serra, et al.
British Journal of Cancer|April 4, 2013
Putative tumour suppressor gene necdin is hypermethylated and mutated in human cancerL E De Faveri, C D Hurst, F M Platt, et al.
Journal of Biological Regulators and Homeostatic Agents|July 9, 2013
Fluorescence in situ hybridization analysis of CCND3 gene as marker of progression in bladder carcinomaA L Beltran, J L Ordonez, A P Otero, et al.
Pageof 1